Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 1, 2002, Pages 49-57

  Bradley, Jeffrey D ^a,c   Ieumwananonthachai, Nantaken ^a   Purdy, James A ^a   Wasserman, Todd H ^a   Lockett, Mary Ann ^a   Graham, Mary V ^b   Perez, Carlos A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Phelps County Regional Medical Center   (United States)

^c Radiation Oncology Center   (United States)

Author keywords

3D conformal radiation therapy; Non small cell lung cancer; Prognostic factors

Indexed keywords

COMPUTERIZED TOMOGRAPHY; DISEASE CONTROL; PULMONARY DISEASES; RADIOTHERAPY; TUMORS;

PROGNOSTIC FACTORS;

PATIENT TREATMENT;

ANTINEOPLASTIC AGENT; CISPLATIN;

ADULT; AGED; ARTICLE; BRACHIAL PLEXUS INJURY; CANCER STAGING; CARDIOTOXICITY; CLINICAL TRIAL; COMPLICATION; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; ESOPHAGITIS; FEMALE; HISTOLOGY; HUMAN; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PERICARDITIS; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE DISTRIBUTION; SURVIVAL; TARGET ORGAN; TECHNIQUE; THERAPY; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY, CONFORMAL; SURVIVAL RATE;

EID: 0036137408     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)01772-2     Document Type: Article

References (28)

1. AJCC cancer staging manual
2. Lung cancer handbook for staging and imaging
3. Tumor volume; A basic and specific response predictor in radiotherapy
4. Clinical prognostic factors in surgically treated Stage IIIA-N2 non-small cell lung cancer; Analysis of the literature
5. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
6. Recursive partitioning analysis of 1,592 patients on four RTOG studies in non-small cell lung cancer
7. Advances in 3-dimensional radiation treatment planning systems; Room-view display with real time interactivity
8. Three-dimensional conformal radiotherapy for lung cancer; The Washington University experience
9. IMEX; A tool for image display and contour management in a windowing environment
10. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
11. Nonparameric estimation from incomplete observations
12. Evaluation of survival data and two new rank order statistics arising in its consideration
13. Regression models and life tables
14. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588; Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer
15. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in Stage III non-small cell lung cancer
16. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with Radiation Therapy Oncology Group Stage III non-small-cell lung carcinoma; Report of Radiation Therapy Oncology Group 83-11
17. Recursive partitioning analysis of 1592 patients on four RTOG studies in inoperable non-small cell lung cancer
18. Volume and dose parameters for survival of non-small cell lung cancer patients
19. Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone
20. Effect of tumor bulk on local control and survival of patients with T1 glottic cancer
21. Prognostic factors of local control after radiotherapy in T1 glottic and supraglottic carcinoma of the larynx
22. The influence of tumor size and morphology on the outcome of patients with FIGO Stage IB squamous cell carcinoma of the uterine cervix
23. The influence of quantitative tumor volume measurements on local control in advanced head and neck cancer using concomitant boost accelerated superfractionated irradiation
24. Stage IB and IIA-B carcinoma of the intact uterine cervix; Impact of tumor volume and the role of adjuvant hysterectomy
25. Point; The potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer
26. Counterpoint; Better irradiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation